Clinical Trials Directory

Trials / Completed

CompletedNCT03604861

An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery

Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study®

Status
Completed
Phase
Study type
Observational
Enrollment
534 (actual)
Sponsor
Indivior Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of participants from studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003). The RECOVER study will characterize OUD subjects' recovery process as they transition from the controlled clinical trial environment to the real world setting.

Conditions

Interventions

TypeNameDescription
OTHERNot applicable - no defined interventionParticipants who received at least one injection of RBP-6000 or placebo and either withdrew from or completed the Phase III clinical program which included studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003) were eligible for the RECOVER Study.

Timeline

Start date
2015-08-01
Primary completion
2019-03-01
Completion
2019-03-01
First posted
2018-07-30
Last updated
2019-04-18

Locations

35 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03604861. Inclusion in this directory is not an endorsement.